[Perfusion MR imaging in brain tumors]

J F Le Bas1, S Grand, A Krainik

  • 1Unité IRM, CHU Grenoble, BP 217, 38043 Grenoble Cedex 9. JFLeBas@chu-grenoble.fr

Journal De Radiologie
|June 17, 2006
PubMed

Insights

Perfusion MR imaging aids in diagnosing and monitoring brain tumors. Dynamic susceptibility contrast MRI offers insights but has limitations in quantifying and interpreting results.

Area of Science:

  • Radiology
  • Neuroimaging
  • Medical Imaging

Background:

  • Perfusion MR imaging is a valuable tool for the evaluation of brain tumors.
  • Dynamic susceptibility contrast (DSC) MR imaging is a key technique in this field.

Observation:

  • This technique involves assessing blood flow and volume in brain tissue.
  • It provides dynamic contrast enhancement data for analysis.

Findings:

  • DSC MRI has demonstrated utility in both initial diagnosis and follow-up of brain tumors.
  • The interpretation of results is discussed, highlighting both advantages and limitations.
  • Challenges in quantification and data interpretation are inherent to the technique.

Implications:

  • Understanding the capabilities and constraints of DSC MRI is crucial for accurate clinical decision-making.
  • This imaging modality can significantly impact patient management strategies for brain tumors.
  • Further research may focus on refining quantification methods for improved diagnostic accuracy.

Related Concept Videos